Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-24-002121

Chief Financial Officer acquired 116,690 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kelly John Alexander Chief Financial Officer 2024-01-20 Option exercise +116,690 614,169 D
Derivatives
Kelly John Alexander Chief Financial Officer 2024-01-20 Option exercise · Restricted Stock Units −116,690 233,310 D
Loading xslF345X05/doc4.xml…